Rein Julius MD - Suffern, New York 10901

Rein Julius MD is categorized under Doctors in Suffern, NY .

Business Name: Rein Julius MD
Contact Person: Julius Rein
Address: 133 Lafayette Avenue, Suffern, New York 10901
Phone Number: (845) 357-5770
Website Address: ramapoanesthesia.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Berkowitz Bennett J MD - Suffern, NY 10901
Singaravelu Dakshinamur MD - Suffern, NY 10901
Medina Felix A MD - Suffern, NY 10901
Clarkin Richard P MD - Suffern, NY 10901
Xiong Tiexin MD - Suffern, NY 10901
Palop Ricardo MD - Suffern, NY 10901
Burns Paul MD - Suffern, NY 10901
Muhlbauer David J MD - Suffern, NY 10901
Mudric-Tiganu Brindusa MD - Suffern, NY 10901
Tash Robert R MD - Suffern, NY 10901
Rosner Victor MD - Suffern, NY 10901
Song Michael M MD - Suffern, NY 10901
Bhana Mahomed MD - Suffern, NY 10901
Thomas L Facelle - Suffern, NY 10901
Peter T Simonson Pllc - Suffern, NY 10901
Tenembaum Gabriel MD - Suffern, NY 10901
Mark M S Khilnani M D P C - Suffern, NY 10901
C Melcer Md - Suffern, NY 10901
Van Roekens Craig N MD - Suffern, NY 10901
Leonard Steinfeld Inc - Suffern, NY 10901

The company Rein Julius MD provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Rein Julius MD, and the business now earns $500.000 to $999.999 per annum.

Rein Julius MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Rein Julius MD, please call Julius Rein with the phone number (845) 357-5770 or visit its single location at 133 Lafayette Avenue in Suffern, New York 10901.

The location of the single location can also be found using the coordinates 41.115024,-74.147769. Read more details about this business on the webpage ramapoanesthesia.com or follow the company’s social media accounts, on Twitter and on Facebook.